Project Grant K23MH140114
- Federal Grant Award Summary Boston University Medical Campus received a $191,972 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on September 8, 2025, with a completion date of August 31, 2030. The award supports a pilot randomized controlled trial examining an adapted form of Cognitive Processing Therapy (CPT) for posttraumatic stress disorder (PTSD) in populations experiencing health disparities. The...
- Federal Grant Award Summary Boston Medical Center Corporation received a $939,784 Project Grant from the National Institute of Mental Health (Mental Health Research Grants, CFDA 93.242) awarded August 1, 2025, through July 31, 2030. The grant supports development and implementation of an adaptive (stepped) intervention designed to improve access, engagement, and effectiveness of posttraumatic stress disorder (PTSD) treatment in routine care settings. The intervention sequences a digital...
- Federal Project Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Virginia $160,579 under the Mental Health Research Grants program (CFDA 93.242) for a project grant commencing September 1, 2025, and concluding August 31, 2029. The award supports Dr. Lora Henderson Smith's research to adapt Safe Alternatives for Teens and Youths-Acute (SAFETY-A), a cognitive behavioral therapy-informed intervention originally delivered in emergency department (ED)...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $1.13M project grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded May 7, 2025, with completion targeted for February 28, 2029. The research initiative investigates the structural and functional architecture of cortico-cerebellar systems in posttraumatic stress disorder (PTSD) and trauma exposure. The project addresses a...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $743,045 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 20, 2025, with completion scheduled for August 31, 2030. This award supports a five-year research project investigating the long-term consequences of extinction enhancement as a therapeutic intervention for post-traumatic stress disorder (PTSD). The...
- Federal Grant Award Summary The University of Southern California received a $196,236 Project Grant award from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242), effective September 1, 2025 through August 31, 2029. This K23 career development award supports a four-year training and research initiative to develop early interventions for preventing Post-Traumatic Stress Disorder (PTSD) in burn survivors and their caregivers. The project...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded $750,653 to Parc Innovations LLC on April 16, 2025, under the Mental Health Research Grants program (CFDA 93.242) to develop an automated e-learning platform for therapist training in exposure therapy. The project will create an interactive digital training system that automates both didactic and interactive components of evidence-based exposure therapy training modules previously developed through NIMH-funded...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $770,654 Project Grant to the University of Texas at Austin on June 1, 2025, under the Mental Health Research Grants program (CFDA 93.242) to conduct research on exercise-enhanced fear extinction in individuals with post-traumatic stress disorder (PTSD). The research will investigate whether moderate-intensity aerobic exercise delivered during or after fear extinction learning can improve the efficacy of...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $675,129 Project Grant award from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) for research spanning April 1, 2026, through January 31, 2031. This award supports the development and evaluation of Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure for Adolescents (COPE-A), an integrated, trauma-focused intervention designed...
- Boston University Medical Campus received a $567,000 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 8, 2025, with completion targeted for September 7, 2028. The grant funds research to augment Cognitive Processing Therapy (CPT) with peer-led support interventions designed to improve mental well-being and enhance PostTraumatic Stress Disorder (PTSD) recovery outcomes in vulnerable populations....
The National Institute of Mental Health (NIMH) awarded The Medical University of South Carolina a $208,794 Project Grant on March 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support a K23 research and training initiative led by Dr. Emily Tilstra-Ferrell. The grant funds the development and testing of an adapted written exposure therapy (WET) intervention for adolescents with posttraumatic stress disorder (PTSD). Through this five-year award (concluding February 28, 2031), the project will systematically adapt WET—an evidence-based, five-session treatment originally developed for adults—using the ADAPT-ITT framework, conduct a proof-of-concept randomized controlled trial comparing WET to trauma-focused cognitive behavior therapy in a pediatric primary care setting, and examine potential mechanisms of action related to fear extinction and cognitive processes. This research directly addresses a critical clinical gap in adolescent mental health treatment, as over four million U.S. adolescents have PTSD yet only 37% access evidence-based treatments, with over one-third of those who do access care dropping out prematurely due to lengthy protocol requirements. By condensing treatment from longer standard protocols to five sessions, WET aims to reduce treatment barriers and costs while maintaining clinical efficacy, thereby improving accessibility and completion rates for this vulnerable population in real-world, multidisciplinary healthcare settings.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $208.8k | 3/2/26 |